Patient-Defined Outcome Endpoints: A Paradigm Shift in Evaluating Atrial Fibrillation Ablation Efficacy - 29/06/21
Doi : 10.1016/j.hlc.2021.05.089
Devika Nair, MD, MSCI a, ⁎ 
, Gregory F. Michaud, MD b, Kerri L. Cavanaugh, MD, MHS a, c
, Gregory F. Michaud, MD b, Kerri L. Cavanaugh, MD, MHS a, c a Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN, USA
b Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
c Center for Effective Health Communication, Vanderbilt University Medical Center, Nashville, TN, USA
∗Corresponding author at: Assistant Professor of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 450, Nashville, TN 37203, USAAssistant Professor of MedicineDivision of Nephrology and HypertensionVanderbilt University Medical Center2525 West End AvenueSuite 450NashvilleTN37203USA
Keywords : Patient-defined endpoints, Atrial fibrillation, Patient-reported outcomes
El texto completo de este artículo está disponible en PDF.
Esquema
© 2021
Publicado por Elsevier Masson SAS.
Vol 30 - N° 8
P. 1103-1106 - août 2021 Regresar al número
Artículo precedente
- Editorial Board
- Underusage of Oral Anticoagulation in Atrial Fibrillation: Can We Prevent More Strokes?
- Karan Rao, Ravinay Bhindi
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?